MAPT and Mental deterioration: More broadly, it is also expected that tau imaging could help with disease staging and to address unanswered questions pertaining to how amyloid-β and tau, both independently and via synergistic interactions, result in cognitive decline, and their relationships with other pathologies such as TDP-43 and α-synuclein, when tracers for these targets become available.